Improved Penile Histology by Phalloidin Stain: Circular and Longitudinal Cavernous Smooth Muscles, Dual-endothelium Arteries, and Erectile Dysfunction-associated Changes-Reference-Cited by-同舟云学术

Improved Penile Histology by Phalloidin Stain: Circular and Longitudinal Cavernous Smooth Muscles, Dual-endothelium Arteries, and Erectile Dysfunction-associated Changes

Published:2011-10 Issue:4 Volume:78 Page:970.e1-970.e8
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Lin Guiting,Qiu Xuefeng,Fandel Thomas M.,Albersen Maarten,Wang Zhong,Lue Tom F.,Lin Ching-Shwun

Publisher

Elsevier BV

Subject

Urology

Reference26 articles.

1. Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat;Ferrini;J Sex Med,2009

2. Lack of direct androgen regulation of PDE5 expression;Yang;Biochem Biophys Res Commun,2009

3. The interaction of phalloidin;Löw;FEBS Lett,1974

4. Phalloidin-induced actin polymerization in the cytoplasm of cultured cells interferes with cell locomotion and growth;Wehland;Proc Natl Acad Sci U S A,1977

5. Coumarin-phalloidin: a new actin probe permitting triple immunofluorescence microscopy of the cytoskeleton;Small;J Cell Sci,1988

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Stem Cell Therapy on Diabetic Mellitus Erectile Dysfunction: A Systematic Review and Meta-analysis;The Journal of Sexual Medicine;2022-01

2. Nuclear Actin Dynamics in Gene Expression, DNA Repair, and Cancer;Nuclear, Chromosomal, and Genomic Architecture in Biology and Medicine;2022

3. Anatomic variation and orgasm: Could variations in anatomy explain differences in orgasmic success?;Clinical Anatomy;2016-04-04

4. Advances in Stem Cell Therapy for Erectile Dysfunction;Advances in Andrology;2014-03-12

5. Synergistic Effects of BAY 60‐4552 and Vardenafil on Relaxation of Corpus Cavernosum Tissue of Patients with Erectile Dysfunction and Clinical Phosphodiesterase Type 5 Inhibitor Failure;The Journal of Sexual Medicine;2013-05